Skip to main content

Published locations for Cetuximab plus FOLFIRI in first-line treatment of KRAS mutation-negative, EGFR-positive metastatic colorectal cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Cetuximab plus FOLFIRI in first-line treatment of KRAS mutation-negative, EGFR-positive metastatic colorectal cancer

User login

  • Reset your password
  • /content/cetuximab-plus-folfiri-first-line-treatment-kras-mutation-negative-egfr-positive-metastatic
  • /jcso/article/56919/gastroenterology/cetuximab-plus-folfiri-first-line-treatment-kras-mutation
  • /hematology-oncology/article/56919/gastroenterology/cetuximab-plus-folfiri-first-line-treatment-kras